May. 7 at 5:05 PM
$VXLLF Vaxil announces that it will be consolidating all of the issued and outstanding common shares of the Company ("Common Shares") on the basis of one (1) post consolidation Common Share for each fifty (50) pre consolidation Common Shares (the "Consolidation").
The Corporation's board of directors set May 15, 2025 as the effective date of the Consolidation. Trading of the Common Shares on a post-Consolidation basis on the TSX Venture Exchange (the "TSXV") will commence on or about May 15, 2025. The Company's name and trading symbol will remain unchanged. The Consolidation is subject to the approval of the TSXV.
